Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.52 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1549076 | 0.86 | CSNK2A1 (0.53) | CSNK2A1BRD4MEN1KMT2AALDH1A1 | |
| SCHEMBL29140046 | 0.85 | CSNK2A1 (0.48) | CSNK2A1BRD4MEN1KMT2AALDH1A1 | |
| SCHEMBL9912234 | 0.84 | CSNK2A1 (0.57) | CSNK2A1MEN1KMT2AALDH1A1POLB | |
| SCHEMBL7774557 | 0.82 | CSNK2A1 (0.50) | CSNK2A1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL20943211 | 0.82 | CSNK2A1 (0.50) | CSNK2A1BRD4MEN1KMT2AALDH1A1 | |
| SCHEMBL18280409 | 0.82 | CSNK2A1 (0.50) | CSNK2A1BRD4MEN1KMT2AALDH1A1 | |
| SCHEMBL4638489 | 0.82 | PARP1 (0.46) | CSNK2A1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL2336414 | 0.82 | SRC (0.54) | CSNK2A1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30388279 | 0.82 | CSNK2A1 (0.50) | CSNK2A1BRD4MEN1KMT2AALDH1A1 | |
| SCHEMBL15462885 | 0.82 | CSNK2A1 (0.50) | CSNK2A1BRD4MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230133817-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| EP-1890992-B1 | AN ENRICHMENT PROCESS USING COMPOUNDS USEFUL IN A POLYESTER PROCESS | GRUPO PETROTEMEX SA DE CV (MX) | 2019-10-23 | — | — | EP | disclosed |
| EP-1888498-B1 | A PROCESS TO PRODUCE AN ENRICHMENT FEED | GRUPO PETROTEMEX SA DE CV (MX) | 2019-06-26 | — | — | EP | disclosed |
| EP-1888497-B1 | A PROCESS TO PRODUCE AN ENRICHED COMPOSITION THROUGH THE USE OF A CATALYST REMOVAL ZONE AND AN ENRICHMENT ZONE | GRUPO PETROTEMEX SA DE CV (MX) | 2019-04-17 | — | — | EP | disclosed |
| EP-2066612-B1 | A PROCESS TO PRODUCE AN ENRICHMENT FEED | GRUPO PETROTEMEX SA DE CV (MX) | 2018-08-01 | — | — | EP | disclosed |
| US-10029973-B2 | Optimized liquid-phase oxidation | GROPO PETROTEMEX, S.A. DE C.V. (MX) | 2018-07-24 | — | — | US | disclosed |
| US-20180072648-A1 | OPTIMIZED LIQUID-PHASE OXIDATION | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2018-03-15 | — | — | US | disclosed |
| EP-2316566-B1 | Bubble column reactor for gas-liquid exchange reactions | GRUPO PETROTEMEX SA DE CV (MX) | 2017-11-22 | — | — | EP | disclosed |
| EP-1791800-B1 | OPTIMIZED LIQUID-PHASE OXIDATION | GRUPO PETROTEMEX SA DE CV (MX) | 2017-11-01 | — | — | EP | disclosed |
| EP-1881953-B1 | A PROCESS TO PRODUCE AN ENRICHED CARBOXYLIC ACID COMPOSITION | GRUPO PETROTEMEX SA DE CV (MX) | 2017-10-25 | — | — | EP | disclosed |
| US-20060047155-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047151-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047149-A1 | Optimized liquid-phase oxidation | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047157-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047154-A1 | Optimized liquid-phase oxidation | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047142-A1 | Optimized liquid-phase oxidation | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| US-20060047161-A1 | Optimized liquid-phase oxidation | ALPEK POLYESTER, S.A. DE C.V. (MX) | 2006-03-02 | — | — | US | disclosed |
| EP-0081611-B1 | PROCESS FOR ELECTROCHEMICAL REDUCTION OF TEREPHTHALIC ACID | AMOCO CORPORATION (US) | 1985-10-09 | — | — | EP | disclosed |
| EP-0081611-A1 | Process for electrochemical reduction of terephthalic acid | AMOCO CORPORATION (US) | 1983-06-22 | — | — | EP | disclosed |
| US-4381229-A | Process for electrochemical reduction of terephthalic acid | STANDARD OIL COMPANY (INDIANA) (US) | 1983-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133817-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | CSNK2A1 1833/4885BRD4 1705/4885MEN1 2531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.